Invention Grant
- Patent Title: Use of morphinan derivatives for treatment of opioid delta receptor agonist-related disease
-
Application No.: US18081842Application Date: 2022-12-15
-
Publication No.: US12109209B2Publication Date: 2024-10-08
- Inventor: Hiroshi Nagase , Hideaki Fujii , Akiyoshi Saitoh , Eriko Nakata , Masaaki Hirose , Isao Ooi , Kohei Hayashida
- Applicant: NIPPON CHEMIPHAR CO., LTD.
- Applicant Address: JP Tokyo
- Assignee: NIPPON CHEMIPHAR CO., LTD.
- Current Assignee: NIPPON CHEMIPHAR CO., LTD.
- Current Assignee Address: JP Tokyo
- Agency: GREENBLUM & BERNSTEIN, P.L.C.
- Priority: JP 16203925 2016.09.16
- Main IPC: A61K31/485
- IPC: A61K31/485 ; A61P25/04 ; A61P25/06 ; A61P25/22
Abstract:
A method for therapeutic treatment of pain-associated anxiety or depression in a mammalian subject in need thereof, that includes administering to the subject an effective amount of a pharmaceutical composition containing a morphinan derivative that exhibits an opioid δ receptor agonist activity.
Public/Granted literature
- US20230132191A1 USE OF MORPHINAN DERIVATIVES FOR TREATMENT OF OPIOID DELTA RECEPTOR AGONIST-RELATED DISEASE Public/Granted day:2023-04-27
Information query
IPC分类:
